Aventis Accepts $65.3 Billion Sanofi Takeover Bid; Deal Would Create World s 3rd Biggest Pharma | GenomeWeb

NEW YORK, April 26 (GenomeWeb News) - After having previously put up heavy resistance to a hostile takeover bid by French drug maker Sanofi-Synthelabo, Aventis said yesterday that it is recommending its shareholders accept the deal in light of improved terms.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.